Panacea Biotec informs about board meeting

31 Jan 2025 Evaluate

Pursuant to Regulation 29 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (‘SEBI LODR Regulations’), Panacea Biotec has informed that: (i) the meeting of the Board of Directors of the company is scheduled to be held on Friday, February 14, 2025 at New Delhi, to consider and approve the Standalone and Consolidated Unaudited Financial Results (Provisional) for the quarter and nine months ended December 31, 2024; (ii) pursuant to Regulation 46(2) of the SEBI LODR Regulations, notice of the said meeting is also being uploaded on the website of the Company; and (iii) with reference to its earlier announcement dated December 26, 2024 intimating the Closure of Trading Window pursuant to the Company's Code of Conduct for Prevention of Insider Trading framed in accordance with the SEBI (Prohibition of Insider Trading) Regulations, 2015, as amended from time to time, the trading window of the Company shall remain closed for all Designated Persons of the Company till February 16, 2025. 

The above information is a part of company’s filings submitted to BSE.

Panacea Biotec Share Price

431.90 -9.45 (-2.14%)
25-Mar-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1766.00
Dr. Reddys Lab 1180.55
Cipla 1510.65
Lupin 2068.70
Zydus Lifesciences 907.45
View more..
© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.
Please wait your portfolio is updating...